MENU
+Compare
POLBF
Stock ticker: OTC
AS OF
Jul 10 closing price
Price
$0.04
Change
-$0.00 (-0.00%)
Capitalization
28.05M

POLBF Poolbeg Pharma Plc Forecast, Technical & Fundamental Analysis

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to development of multiple products faster and more cost-effectively than the traditional biotech model... Show more

POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for POLBF with price predictions
Jul 18, 2025

POLBF's Stochastic Oscillator is sitting in overbought zone for 4 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.383) is normal, around the industry mean (18.130). P/E Ratio (0.000) is within average values for comparable stocks, (58.963). POLBF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.526). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (271.880).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. POLBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POLBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
42 New Road
Phone
+44 2071831499
Employees
6
Web
https://www.poolbegpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGPKY6.200.11
+1.81%
PGE Polska Energetyczna SA
HOKCY0.76N/A
+0.16%
Hong Kong & China Gas Co., Ltd.
VBIZF0.19N/A
N/A
Viva Biotech Holdings
EQTL1.00N/A
N/A
Equitech Int'l Corp.
GHYLF0.40N/A
N/A
Gold Hydrogen Limited

POLBF and Stocks

Correlation & Price change

A.I.dvisor tells us that POLBF and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
NNVC - POLBF
26%
Poorly correlated
+2.50%
BOLT - POLBF
26%
Poorly correlated
N/A
BEIGF - POLBF
25%
Poorly correlated
N/A
DSGN - POLBF
25%
Poorly correlated
-3.13%
ALXO - POLBF
22%
Poorly correlated
+5.35%
More